Evidence map›Paper›PMID 18704959›Full record

ArticleAmerican journal of hematology2008

Ankyrin-linked hereditary spherocytosis in an African-American kindred.

Jose Sangerman, Yelena Maksimova, E Jennifer Edelman, Jon S Morrow, Bernard G Forget, Patrick G Gallagher

Open access · greenAbstract read
In one paragraph

Article in American journal of hematology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Forward Genetics in Apicomplexa Biology: The Host Side of the Story.Frontiers in cellular and infection microbiology · 2022
    Review
  2. Article
  3. Review
  4. Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants.Journal of perinatology : official journal of the California Perinatal Association · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jose SangermanDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520-8064, USA.
Yelena Maksimova
E Jennifer Edelman
Jon S Morrow
Bernard G Forget
Patrick G Gallagher
Yale University · US

Funding

RESEARCH IN PERINATAL MEDICINET32HD007094 · NICHD · YALE UNIVERSITY · PI GALLAGHER, PATRICK G · 1985 to 2015
$3.6M
Molecular Biology of Erythrocyte AnkyrinR01DK062039 · NIDDK · YALE UNIVERSITY · PI GALLAGHER, PATRICK G · 2002 to 2010
$3.3M
MEMBRANE SKELETAL CONTROL IN HEMOLYTIC DISORDERSR01HL028560 · NHLBI · YALE UNIVERSITY · PI MORROW, JON S · 1985 to 2011
$3.3M
Molecular Genetics of the Red Cell Membrane SkeletonR01DK019482 · NIDDK · YALE UNIVERSITY · PI FORGET, BERNARD G · 1986 to 2006
$1.7M
NHLBI NIH HHS R01 HL028560NICHD NIH HHS T32 HD007094NICHD NIH HHS T32 HD07094NIDDK NIH HHS R01 DK019482NIDDK NIH HHS R01 DK062039NIDDK NIH HHS R01DK19482NIDDK NIH HHS R01DK62039
6 · The paper itself

Abstract

Mutations of ankyrin-1 are the most frequent cause of the inherited hemolytic anemia, hereditary spherocytosis (HS), in people of European ancestry. Ankyrin-1, which provides the primary linkage between the erythrocyte membrane skeleton and the plasma membrane, has numerous isoforms generated by alternative splicing, alternate polyadenylation, use of tissue-specific promoters, and alternate NH(2) or COOH-termini. Mutation detection in erythrocyte membrane protein genes, including ankyrin, has been a challenge, primarily due to the large size of these genes, and the apparent frequent occurrence of HS-associated null alleles. Using denaturing high-performance liquid chromatography (DHPLC), we screened the ankyrin gene of the proband of a large, three generation African-American kindred with ankyrin-deficient HS. DHPLC yielded an abnormal chromatogram for exon 1. Examination of the corresponding exon 1 sequence in genomic DNA from the proband revealed heterozygosity for a mutation of the initiator methionine (ATG to ATA Met 1 Ile). Coupled in vitrotranscription/translation studies with rabbit reticulocyte lysates demonstrated that the wild-type ankyrin erythroid cDNA initiates only from the known initiator methionine, indicating that the use of alternate initiator methionine is not a mechanism of isoform diversity in erythroid cells. The mutant ankyrin allele, unlike some initiator methionine mutations that utilize downstream codons for translation initiation, was associated with a null allele. This is the first report describing ankyrin-linked HS in an African-American kindred.

Indexed as

AllelesAnkyrinsBase SequenceBlack or African AmericanCase-Control StudiesChromatography, High Pressure LiquidCodonDNA Mutational AnalysisExonsFamilyFemaleGene FrequencyGenetic TestingHeterozygoteHumansMaleAnkyrinsCodon

Identifiers

PMID18704959
PMCPMC11304496
OpenAlexW1999908297

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.